Clinical Trials Browser

NCT02518555 2026-04-06

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2 Completed

42 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03955991 2025-06-26

VSMART

Phase 4 Completed

109 enrolled

Breast

Breast Neoplasms, Influenza, Human

NCT06124131 2025-05-04

BENEFIT-C

Phase NA Completed

50 enrolled 15 charts

Gastrointestinal

Vaccine-Preventable Diseases, COVID-19, Vaccination Hesitancy, Influenza, Human, Patient Acceptance of Health Care, Colorectal Neoplasms, Health Behavior

NCT04080531 2025-02-28

Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders

Phase 4 Completed

165 enrolled 9 charts

Plasma cell

Neoplasms, Plasma Cell

NCT02860039 2024-10-22

High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant

Phase 2 Completed

170 enrolled 11 charts

Influenza, Human, Neoplasms

NCT04484532 2023-06-06

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Phase EARLY_PHASE1 Completed

130 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT02998736 2022-12-28

PERIOP-04

Phase 1 Completed

28 enrolled

Abdominal Cancer

NCT04591379 2022-12-13

Intratumoral Influenza Vaccine for Early Colorectal Cancer

Phase 2 Completed

10 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03590808 2019-09-19

Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Phase NA Completed

143 enrolled

Influenza, Human

NCT02566265 2019-01-30

SHIVERING 2

Phase 2 Completed

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT01941758 2018-07-05

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Phase 1 Completed

28 enrolled

CNS

Central Nervous System Neoplasms

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

Phase 2 Completed

85 enrolled 24 charts

Influenza, Human, Neoplasms

NCT01666782 2016-06-24

IMMUNE

Phase 2 Completed

105 enrolled 10 charts

Influenza, Human, Neoplasms

NCT01707628 2014-01-31

Rituxivac

Phase NA Completed

98 enrolled

Lymphoid

Influenza, Human, Lymphoma, Non-Hodgkin

NCT00022035 2013-01-31

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Phase NA Completed

Other hematologic neoplasm

Infections, Leukemia

NCT01031719 2012-09-13

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Phase 3 Completed

59 enrolled

Influenza, Human, Neoplasms, Virus Diseases